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ber 11, 2018. For personal use onHeart failure (HF) is a clinical syndrome characterized by typical symptoms
and signs caused by structural or functional cardiac abnormalities, resulting in
a reduced cardiac output or elevated intracardiac pressures at rest or during
stress.1 The prevalence of HF is approximately 1%-2% of the adult population
in developed countries, rising to 10% among people >70 years of age, and it
is the leading cause of hospitalization.2
The main terminology used to describe HF is historical and is based on
the measurement of the left ventricular ejection fraction (LVEF).1 HF
comprises a wide range of patients, from those with normal LVEF (HF
with preserved ejection fraction [EF], heart failure with preserved ejec-
tion fraction) to those with reduced LVEF (HF with reduced EF, heart
failure with reduced ejection fraction). Patients with an LVEF in the
range of 40%-49% represent a “grey area”, which is now defined as heart
failure with mid-range ejection fraction (HF with mid-range EF).
According to the current guidelines,1 echocardiography is considered
the most useful and widely available test in HF patients. It provides
immediate information on chamber volumes, ventricular systolic, and
diastolic function, wall thickness, valve function and pulmonary hyper-
tension. This information is crucial in establishing the diagnosis and in
determining appropriate treatment.
Nevertheless, ultrasound examinations other than echocardiography,
give substantial information both during hospitalization and in the fol-
low-up of HF patients. Over the last 2 decades, the concept of using
sonography as a real-time bedside clinical tool (point of care) in the hands
of the same physician who is treating the patient is obtaining a growing
consensus.3 Among them, lung ultrasound (LUS), with the quantification
of the B-lines, is surely the most innovative and also the simplest to learn.Curr Probl Cardiol, 00 2018 Azienda Ospedaliera Universitaria Integrata Verona from ClinicalKey.com by Elsevier on
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the fluids in the lungs causes pulmonary interstitial fluid and alveolar
edema, which is the main cause of hospitalization. LUS and cava vein
monitoring by the quantification of the collapsibility index, inferior cava
vein collapsibility index (ICVCI), are considered efficient tools in moni-
toring the congestion recovery in HF patients.4
But the cardiovascular risk assessment of these patients may include
also the peripheral vessels examination. In this perspective, carotid,
abdominal aorta, and peripheral arteries evaluation may represent an
integrative approach. So this article aims at reviewing evidence of the
importance of ultrasound in HF both for hospitalized patients and in the
follow-up. Ultrasound may be used as a recovery monitoring instrument
at the bedside and also as a global cardiovascular assessment tool for
these patients.Focus on: Heart Failure and the Ankle Brachial Index
The ankle brachial index (ABI) is a marker of generalized atheroscle-
rosis. It is predictive of future cardiovascular events.Curr Probl Cardiol, 00 2018 3
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peripheral artery disease.5-7
The ABI carries prognostic information related to all-cause mortality,
cardiovascular death, and nonfatal cardiovascular events, including coro-
nary heart disease and stroke.
The association between ABI and incident HF has been characterized.
The Cardiovascular Health Study demonstrated that an ABI < 0.90 was
independently associated with an increased risk of HF among participants
without prevalent coronary heart disease.8
The Atherosclerosis Risk in Communities Study9 described the
relationship between ABI and the risk for HF. In a community cohort
of middle-aged Americans, it has been found that a low ABI was
associated with a 40% higher risk of HF than a normal ABI, and a
borderline ABI was also associated with an increased risk of HF.
Authors analyzed a middle-aged community cohort with ABI  1.00.
It was significantly associated with an increased risk of HF indepen-
dent of traditional HF risk factors, prevalent coronary artery disease,
and carotid atherosclerosis. Authors hypothesized that an altered
ABI may be a risk marker for HF. Mechanistically, a low ABI may
be a marker for abnormal vascular stiffness and atherosclerotic
microvascular dysfunction which may contribute to the pathogenesis
of HF even in the absence of clinically apparent coronary
artery disease.
It has been found10 that greater aortic stiffness (reflected by higher
carotid and/or femoral pulse wave velocity) was associated with
increased risk of HF. Arterial stiffness has been recognized as a marker
of cardiovascular disease and associated with long-term worse clinical
outcomes in several populations. Arterial stiffness is increased in advanc-
ing age, and has been recognized as an independent risk factor for cardio-
vascular disease. Pulse wave velocity (PWV) is recognized as the gold
standard measurement of arterial stiffness, thus a higher PWV is known
as a significant predictor of cardiovascular morbidity and mortality in
older subjects.
In a recent study11 it was found that low and borderline ABIs were
strongly associated with future HF in hospitalized cardiology
patients. There are many factors, including arterial stiffness that can
contribute to the onset of HF. Brachial ankle PWV was found
increased with decreasing ABI. Thus, increasing PWV may be a key
to explaining the association between decreasing ABI and the
increased incidence of new-onset HF.4 Curr Probl Cardiol, 00 2018
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previous HF has been assessed.12 Authors found that low and border-
line ABI were strong predictors for future incident HF in patients
without previous HF. The cumulative incidence of HF was signifi-
cantly higher in patients with low and borderline ABI than in those
with normal ABI. In multivariate analysis, low ABI and borderline
ABI were independent predictors of incident HF.
Furthermore, in the Multi Ethnic Study of Atherosclerosis,13
authors observed that less compliant arteries were significantly asso-
ciated with low ABI in cross-sectional analysis and with greater
decline in ABI over time, using linear and logistic regression models
on baseline data from 2803 female and 2558 male participants. A low
ABI was associated with noncompliant small vessels, which in
turn, has been associated with an increased risk for adverse cardio-
vascular events, including HF.Focus on: Heart Failure and the B Lines in Lung Ultrasound
In recent years, LUS has been demonstrated to be a valid tool for
the assessment of pulmonary congestion14,15 through the quantifica-
tion of the B-lines.
B-lines are laser-like vertical hyperechoic reverberation artefacts
that appear from the pleural line (also defined as “comet tails” or bet-
ter yet “ring-downs”). Multiple B-lines can be the sonographic sign
of lung interstitial syndrome. Their number increases along with
decreasing air content and increase in lung density.3,16 Many authors
report that clearing of B-lines significantly correlates with improved
clinical symptoms and signs of HF.3,14-16
Their regular distribution allows the differentiation between car-
diogenic pulmonary edema, acute respiratory distress syndrome, and
pulmonary fibrosis.3,16
LUS is emerging as an important tool in critical care for the early
diagnosis of acute respiratory failure.17,18 The “decision tree” used
to guide this diagnosis is the well-known bedside lung ultrasound
evaluation protocol.19 This protocol is based on rapidity. But LUS
can be also used as a monitoring tool in HF patients.Curr Probl Cardiol, 00 2018 5
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 SeptembRecently20 our group has confirmed the potential of LUS in tailoring
diuretic therapy and speeding up the discharge time in HF hospitalization.
In this study the reduction of the B-lines did not occur in accordance with
the aminoterminal portion of B type natriuretic peptide levels, suggesting
that serum aminoterminal portion of B type natriuretic peptide may not
reliably indicate pulmonary congestion having been resolved. These
results lead to consider this molecule as a useful marker for the discrimi-
nation of the possible origin of respiratory failure, but it is not so precise
in monitoring HF recovery.
Different studies21-23 have been designed in different settings other
than Internal Medicine and Emergency.
The advantages of using LUS in the Internal Medicine department are
well-established: the operator is not blinded to the patients’ clinical situa-
tion, the examination could be performed at the bedside, it is cheap and
safe. These studies have confirmed that the B-lines are prognostic
markers for hospital re-admission or death in HF patients.Curr Probl Cardiol, 00 2018
ed for Anonymous User (n/a) at Azienda Ospedaliera Universitaria Integrata Verona from ClinicalKey.com by Elsevier on
er 11, 2018. For personal use only. No other uses without permission. Copyright ©2018. Elsevier Inc. All rights reserved.
ARTICLE IN PRESS
 Downlo
 SeptemFocus on: Heart Failure and the Vascular Assessment,
Carotid Ultrasonography and Intima Media Thickness,
Inferior Cava Vein, and Abdominal Aorta Diameter
Carotid-wall intima-media thickness is a surrogate measure of athero-
sclerosis and it is associated
with cardiovascular risk factors and with cardiovascular outcomes.24-27
There is evidence of a direct relationship between increased carotid
intima media thickness (IMT) and reduced left ventricular systolic
and diastolic function assessed by myocardial strain in asymptomatic
individuals without previous clinically evident cardiovascular
disease.28
Previous cross-sectional analysis using data from the Atheroscle-
rosis Risk in Communities Cohort showed that participants with HFCurr Probl Cardiol, 00 2018 7
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Atherosclerosis Risk in Communities Study30 used data from the
Atherosclerosis Risk in Communities Cohort Study cohort to exam-
ine the hypothesis that subclinical atherosclerosis, assessed by mean
carotid IMT, was associated with incident HF. Authors found that
mean carotid IMT was significantly higher for subjects with HF. The
association of carotid IMT with HF remained significant after
adjustment for blood pressure, and other traditional cardiovascular
risk factors.
Increasing carotid IMT leads to structural changes of the artery
wall, which result in the deposition of collagen in the intracellular
matrix and a decrease in arterial distensibility, causing increased
pressure afterload, pressure wave propagation, and eventually dia-
stolic dysfunction.31-33
Some prospective and cross-sectional studies have established an
association between increasing carotid IMT and regional left ventricular
myocardial systolic and diastolic dysfunction.34,35
Aneurysmal aortic dilation may be associated with cardiovascular dis-
ease risk factors and may prognosticate an increased risk of adverse car-
diovascular outcomes.36
The Framingham Heart Study37 showed that enlarged infrarenal
abdominal aortas are independent predictors of incident adverse cardio-
vascular events above traditional risk factors alone.
Similar results were found in the Tromsø study38: authors found
that abdominal aorta aneurysm increases total and cardiovascular
mortality.
The estimation of the right atrial pressure using echocardiographic
measurement of inferior cava vein (IVC) size along with its respiro-
phasic variation is commonly performed.39 Cutoff values and mea-
surement modalities have been established. Inferior cava vein (ICV)
maximum and minimum diameter and its collapsibility index
(ICVCI) are measured in subcostal view in M-mode, 2 cm from the
right atrial junction. ICVCI is calculated according to the formula
[(ICV max¡ICV min)/ICV max] £ 100. The ICVCI% cut-offs are:
>75 (hypovolemia), 40, and 75 (euvolemia) and <40
(hypervolemia).398 Curr Probl Cardiol, 00 2018
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avoid the assessment of confounding factors that may affect the IVC size
and the respirophasic changes.
Even so, ICVCI has been established as a helpful tool in monitoring
HF patients’ responses to diuretic therapy, checking the volume status.
Different studies4,20 propose ultrasonographic measurement of IVC
parameters to guide HF therapy, incorporating it in the routine ultrasound
assessment of the patient.
To summarize, caution is needed and the ICV evaluation alone is not
recommended for assessing the volume status of the patient. In a simpler
way a maximum diameter of the IVC greater than 2 cm and a collapsibil-
ity less than 40%-50% have good correlation with a central venous pres-
sure > 10 mmHg.40
Focus on: Heart Failure and Echocardiography
Transthoracic echocardiography is the method of choice for the assess-
ment of myocardial systolic and diastolic function of both left and right
ventricles (RVs).1Curr Probl Cardiol, 00 2018 9
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current guidelines.1 This approach is based on the statement that LVEF is
a surrogate marker for left ventricular systolic performance and, in turn,
prognosis. LVEF has proved to be a good predictor of incident HF. In the
CARE trial, with the exception of patient age, LVEF was the most rele-
vant predictor of HF occurrence in 3860 long-term survivors of myocar-
dial infarction without previous history of HF over a 5-year follow-up
period.41
In the VALIANT echocardiography study (610 patients with HF, LV
dysfunction, or both following myocardial infarction) LVEF and LV vol-
umes at baseline were independently predictive of adverse clinical out-
comes (total mortality, cardiovascular mortality, resuscitated sudden
death, hospitalization for HF, and stroke).42
However, LVEF as a measure of LV function has some important limi-
tations. LVEF is measured indirectly by most imaging techniques, includ-
ing echocardiography, which calculate the ejection fraction from
estimations of LV volume. As a volume-derived index, LVEF often relies
on geometric assumptions (particularly in one- and two-dimensional
echocardiography) and is extremely load-dependent. These limitations
lead to substantial loss of reproducibility, and even repeated measures of
ejection fraction in the same individual over a brief time period can result
in a 5- to 7-point variability.
So that, the ESC 2016 Guidelines1 specify that the assessment of RV
structure and function, including RV and right atrial dimensions, anCurr Probl Cardiol, 00 2018
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obligatory elements of echocardiography examination.
In fact, in case of initial evidence of heart failure with preserved ejec-
tion fraction and/or heart failure with mid-range ejection fraction, key
structural and functional signs are shown by alterations in left atrial vol-
ume index, left ventricular mass index, E/e0 and mean septal and lateral
wall.43-45
Also the correct timing for echocardiography has been determined.1
Immediate echocardiography is required in patients with hemodynamic
instability (and cardiogenic shock) and in patients having acute life-
threatening structural or functional cardiac. Immediate echocardiography
should be done in patients with de novo HF and in those with unidentified
cardiac function.
The Guidelines underline that repeated echocardiography is usually
not needed unless there is relevant deterioration in clinical status. Bedside
thoracic ultrasound for signs of interstitial edema and/or pleural effusion
may be convenient in identifying HF, if the expertise is available.
Advanced imaging technologies, as speckle-tracking echocardiogra-
phy, can provide data on regional myocardial function and its specific
components, in particular longitudinal myocardial function, which is
often the earliest component to be affected by disease.
These methodologies are not commonly used in Internal Medicine and
their explanation goes beyond the purpose of this review.
Compared to formal echocardiographic methods for the evaluation of
LVEF, visual estimation (eyeballing) can be done faster, and is often eas-
ier to perform, even in studies with poor visual quality. Among the vari-
ety of terms that have been used to describe a focused ultrasound study of
the heart, the American Society of Echocardiography46 recommends the
use of the term “focused cardiac ultrasound” to indicate a focused exami-
nation of the cardiovascular system by a physician using ultrasound as an
adjunct to the physical examination to recognize specific ultrasonic signs
that represent a narrow list of potential diagnoses in specific clinical set-
tings. The estimation of the eyeballing EF is confirmed as a recom-
mended method especially in contexts other from Cardiology.
Focus on: Ultrasound Limitations (Principally
Concerning B-LUS) and Previous Attempts to Create
Score Systems in Heart Failure
The main disappointment in the area of research of ultrasound in HF
concerns B-LUS and, in particular, the role of the B-lines.Curr Probl Cardiol, 00 2018 11
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Table 1. The "ABCDE" score
A (Ankle-brachial index)
Normal (<90): points 0
Mild obstruction (0.71-0.90): points 1
Moderate obstruction (0.41-0.70): points 2
Severe obstruction 0-0.40): points 3
B (B-lines)
Number of B-lines for each space 5: points 0
Number of B-lines for each space 6 to 9: points 1
Number of B-lines for each space  10 ("Full white screen"): points 3
C (IMT or carotid plaque)
Normal: points 0
Altered IMT (>0.9 mm): points 1
Plaque presence (no significant stenosis, <70% following NASCET classification): points 2
Plaque presence (significant stenosis, >70% following NASCET classification): points 3
D (diameter of aorta and VCI collapsibility index)
Aorta
Normal (<25 mm): points 0
Normal diameter but with calcifications: points 1
Ectasia (25-30 mm): points 2
Aneurysm (>30 mm): points 3
Cava vein
Normal collapsibility index (40%-75%): points 0
Altered collapsibility index (if <40% or >75%): points 1
E (EF according to European Society of Cardiology guidelines 2016)
HFpEF (LVEF 50%): points 0
HFmrEF (LVEF in the range of 40%-49%):points 1
HFrEF (LVEF<40%): points 2
Abbreviations: EF, ejection fraction; HFmrEF, heart failure with mid-range ejection fraction;
HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection
fraction; LVEF, left ventricular ejection fraction; NASCET, North American Symptomatic Carotid
Endarterectomy Trial; VCI, vein collapsibility index.
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in detail. This fact derives from the concept that B-lines are artefacts, so
they are an expression of an error of the ultrasound machine.
Secondly, they are lacking in specificity.
It has to be recognized that the LUS technique in the B-lines identifica-
tion and counting is not fully standardized and many issues against LUS
in HF exist, in particular because of their low specificity in interpreting
the acoustic interactions.47,48
B-lines due to cardiogenic pulmonary edema are usually bilateral, and
usually spread or recover symmetrically.3 Their regular distribution
allows the differentiation between cardiogenic pulmonary edema, acute
respiratory distress syndrome, and pulmonary fibrosis.312 Curr Probl Cardiol, 00 2018
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chymal and pleural diseases and chronic obstructive pulmonary
disease.
Another source of possible pitfall in B-lines detection is the older age
of the patient, as demonstrated.49
In addition, B-lines counting method is another source of possible
errors, concerning both the ways of counting them and the used probe
(type and frequency).
These essays have been largely addressed and caution is mandatory,
principally for two reasons: (1) up to now not precise and largely
accepted counting methods and preferred probe are available; (2) the
patient with HF may be affected by different pulmonary conditions that
confound the images.
Rea and Sperandeo have deeply analyzed these concepts.47,48,50-53
so that, a critical reappraisal of B-lines in HF is required. The overall
clinical picture of the HF patient, conjuncted with biomarkers and other
instrumental examinations are mandatory.
The other issue about HF is the continuous attempt to create scoring
systems for risk stratification, prognosis, future re-admissions for HF.
In these studies54-57 different items have been evaluated (principally
electrocardiogram features, natriuretic peptide levels, serum creatinine
levels, b blocker prescription at discharge, etc.).
In the elderly patient, also the nutrition status, the severity of dementia
and medication adherence have been scored as single parameters,58 also
with different aims from cardiovascular outcome (eg a novel scoring sys-
tem to predict delirium in HF patients).59
As far as we know, with regard to ultrasound, heart LVEF, B-lines
counting and ICV diameter20,60 are usually considered.
But up to now, no precise and integrated ultrasound score systems have
been proposed, neither in hospitalized patient nor in the follow-up.The Purpose of a Score (The “ABCDE” Score) as a Five-
Step Vascular Ultrasound Examination in Heart Failure
In daily practice, HF patient management decisions are an integration
of readily available clinical parameters and values obtained by various
diagnostic techniques, proved to be of prognostic relevance.
In particular, during the last decade, there has been substantial progress
in the use of biomarkers in the clinical management of HF. A broad range
of clinical biomarkers have been rigorously tested in differentCurr Probl Cardiol, 00 2018 13
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nosis, management, follow-up and therapy guidance in HF.
The natriuretic peptides and many markers of inflammation and
oxidative stress have been deeply investigated, as reviewed.61,62
But for the ultrasound side of the matter, the author’s purpose is the cre-
ation of a simple score system for assessing HF patients both at the bedside
(during hospitalization) and for their global cardiovascular assessment.
Authors call this examination: the “ABCDE” score. In detail, it includes
the evaluations of A, the ABI index, B, the B-lines, C, the carotid intima
media thickness, D, the diameter of the abdominal aorta and of the inferior
cava vein and E, the echocardiographic assessment of the ejection fraction.
Patients should undergo: A (calculated for each leg at admission), B-
lines counting (calculated at admission, during hospital stay and at dis-
charge with LUS, approach 72 spaces), C (at admission), D (at admission
for the aorta and at admission, during hospital stay and at discharge for
the ICV) and E (at admission and discharge).
Table 1 represents the ABCDE score, as suggested by the authors on
the basis of the current literature data, as a five-step vascular ultrasound
examination in HF patients.
How to Avoid Pitfalls and Misunderstandings and Create Consistent
Endpoints
In order to avoid the detection of B-lines other than due to HF,
because, as explained, B lines in HF are not an easy issue63; rigorous
technical and study setting features should be performed.
Firstly, exclusion criteria must be strict: concomitant acute coronary syn-
drome, pneumonia, chronic obstructive pulmonary disease, lung cancer or
metastases, lung fibrosis, acute respiratory distress syndrome previous pneu-
monectomy or lobectomy, breast prosthesis, and obesity. It has to be recog-
nized that the LUS technique in the B-lines identification and counting is
not fully standardized and many issues against LUS in HF exist, in particu-
lar because of the low specificity of the B-lines in interpreting the acoustic
interactions. In fact, in this study, precise exclusion criteria have to be
adopted in order to avoid the detection of B-lines other than due to HF.
These strict exclusion criteria are the strength of the study, especially
to clarify the role of the clearing of the B-lines during HF recovery.
In addition, the measurements will be taken by two different physi-
cians, in order to check the agreement of the results.
In addition, age ranges should be limited.
The same probe for all the patient should be used for B-LUS in order to
avoid variability (cardiac probe or convex), due to the fact that no precise
probe is commonly recommended and mandatory for LUS.14 Curr Probl Cardiol, 00 2018
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be scanned applying the well-established protocol,3 that takes more time
but that is feasible in a medical context other from Emergency. The
authors will count the total number of the detectable B-lines in anterolat-
eral and posterior scanning sites.
Going forward, according to Soldati and Zanforlin et al.64,65 the
description of extension (focal and/or bilateral), localization, involvement
(homogeneous and/or dishomogeneous), and gradient of distribution
(gravitational and/or irregular) of the B-lines, as well as features of the
pleural line (rough/smooth/thickened) are pivotal in their better defini-
tion. This topic has been addressed and deeply discussed in the recent
review by Soldati and Demi65: in particular the differences between the
sonographic signs of interstitial syndrome related to lung diseases and
that related to cardiogenic edema have been precisely described.
Finally, the authors can speculate that an interobserver variability could be
limited by at least two different measurements performed by different Medical
Doctors. So the proposed future study could be a milestone in the management
of LUS in the setting of HF (in particular regarding the methodology).
To conclude, an integrated clinical and biochemical characterization of
the patients should be completed.
Endpoints of the Study
The endpoints related to the ABCDE examination should be summa-
rized as follows:
1) Related to the bedside evaluation of HF recovery:C
ad
burr
ed f
er 1- test the association between each item of the ABCDE and the discharge
time (days of hospitalization);
- test the association between B, D (for cava vein) and E assessment and the
number of diuretics shifts during hospitalization and recovery from HF;
- test the association between B, D (for cava vein) and E assessment and natri-
uretic peptide variations and calculated ratio of arterial oxygen partial pressure
to fractional inspired oxygen (PaO2/FiO2 ratio) at admission and discharge;Pr
or
1, 2) Related to the global cardiovascular assessment of the HF patient:
- test the association between each item of the ABCDE and the number of
“events” (death from any cause or re-admission for HF) in a follow up
period (30 and 90 days from discharge);
- test if A, C, and D (for aorta) assessment can better classify the global car-
diovascular risk for the HF patient.obl Cardiol, 00 2018 15
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 SeptemConclusions
HF represents an exciting opportunity to create an integrative ultra-
sound approach in the Internal Medicine and/or Geriatric departments.
The conception of a five-step ultrasound examination (the ABCDE score)
to evaluate and monitor HF patients during hospitalization and follow-up
may be the basis of a future study in these departments.Authors’ Contribution
CM, LC, AC, CS and MS conceived the study; CM wrote the manu-
script.Statement of human and animal rights
The study was conducted in accordance with the ethical standards laid
down in the Helsinki Declaration of 1975 and its late amendments.Informed consent
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